Dimensional Fund Advisors LP Equillium, Inc. Transaction History

Dimensional Fund Advisors LP

  • $376 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023
SELL
$0.83 - $2.26 $2,321 - $6,321
-2,797 Reduced 14.3%
16,767 $17,000
Q3 2022

Nov 10, 2022
BUY
$1.93 - $3.14 $37,758 - $61,430
19,564 New
19,564 $43,000
Q2 2022

Aug 12, 2022
SELL
$1.69 - $3.26 $22,154 - $42,735
-13,109 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$2.99 - $4.19 $8,970 - $12,570
3,000 Added 29.68%
13,109 $41,000
Q4 2021

Feb 09, 2022
BUY
$3.77 - $6.99 $38,110 - $70,661
10,109 New
10,109 $38,000

Others Institutions Holding EQ

# of Institutions
27
Shares Held
11.5M
Call Options Held
38.1K
Put Options Held
0
View Full List

About Equillium, Inc.

EQ Quotes by TradingView
  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $47.1M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email